Deborah Dunsire

CIK 1332764 · President, CEO · last filed 2026-05-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$939.1K

Companies

5

Total Filings

146

Lifetime Open-Market Net

-$1.48M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RARE Director 38,566 $24.35 $939.1K $0 11 2026-05-18
MCK Director $784.05 $0 3 2025-07-31
SYRS Director 12,000 $0.00 $5 $0 6 2024-06-07
ALLERGAN INC (AGN) Delisted Director 35,462 $11.8K 108 2015-02-19
MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted President, CEO 68,899 -$1.50M 11 2008-05-15

Recent Filings · Page 2 of 15

146 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-09-19 SYRS Grant (A) +8,000 $0 EDGAR
2022-06-28 RARE Grant (A) +3,300 $0 EDGAR
2022-06-02 SYRS Grant (A) $0 EDGAR
2021-09-10 SYRS Grant (A) $0 EDGAR
2021-07-23 Disp (D) −14,629 $0
2021-06-28 RARE Grant (A) +2,145 $0 EDGAR
2021-05-24 Grant (A) +2,495 $0
2020-06-30 RARE Grant (A) +2,550 $0 EDGAR
2020-05-18 Grant (A) +4,409 $0
2019-06-13 RARE Grant (A) +3,000 $0 EDGAR
Showing 1120 of 146
Page 2 of 15
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.